Business Description
Zero Candida Technologies Inc
NAICS : 339110
SIC : 3912
ISIN : CA9894831028
Description
Zero Candida Technologies Inc is engaged in providing female healthcare solutions. The company technology uses a controlled Blue Light to destroy the fungus at record speed and without side effects. It focused on developing and commercializing several patents and patent applications concerning an AI smart tampon-like device, designed to treat Candidiasis and transfer medical information via Wi-Fi to the doctor.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 101.86 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.26 | |||||
9-Day RSI | 41.48 | |||||
14-Day RSI | 41.89 | |||||
3-1 Month Momentum % | 3.03 | |||||
6-1 Month Momentum % | -2.86 | |||||
12-1 Month Momentum % | -19.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.27 | |||||
Quick Ratio | 2.27 | |||||
Cash Ratio | 2.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -65.78 | |||||
ROA % | -38.82 | |||||
ROIC % | -3040 | |||||
ROC (Joel Greenblatt) % | -3462.18 | |||||
ROCE % | -65.2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 2.18 | |||||
Price-to-Tangible-Book | 2.21 | |||||
EV-to-EBIT | -0.79 | |||||
EV-to-EBITDA | -0.79 | |||||
EV-to-FCF | -1.3 | |||||
| Price-to-Net-Current-Asset-Value | 2.21 | |||||
| Price-to-Net-Cash | 2.58 | |||||
Earnings Yield (Greenblatt) % | -127.37 | |||||
FCF Yield % | -18.13 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zero Candida Technologies Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.013 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 45.2 | ||
| 14-Day RSI | 41.89 | ||
| 14-Day ATR (C$) | 0.005689 | ||
| 20-Day SMA (C$) | 0.16475 | ||
| 12-1 Month Momentum % | -19.05 | ||
| 52-Week Range (C$) | 0.11 - 0.28 | ||
| Shares Outstanding (Mil) | 19.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zero Candida Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zero Candida Technologies Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zero Candida Technologies Inc Frequently Asked Questions
What is Zero Candida Technologies Inc(TSXV:ZCT)'s stock price today?
The current price of TSXV:ZCT is C$0.16. The 52 week high of TSXV:ZCT is C$0.28 and 52 week low is C$0.11.
When is next earnings date of Zero Candida Technologies Inc(TSXV:ZCT)?
The next earnings date of Zero Candida Technologies Inc(TSXV:ZCT) is .
Does Zero Candida Technologies Inc(TSXV:ZCT) pay dividends? If so, how much?
Zero Candida Technologies Inc(TSXV:ZCT) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025 | 2025-01-06 | ||
| Zero Candida Receives South African Patent for its ZC- 01 device | 2024-12-09 |
Articles on Zero Candida Technologies Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers